Company pipeline · women's health
Sumitomo Pharma women's health pipeline
Sumitomo Pharma is the lead sponsor of 3 active trials in the conditions TrialsForHer tracks (Endometriosis), 2 of them open to recruitment now or about to open.
2open or about to open
3active trials (incl. recruitment ended)
1tracked condition
May 2027next registry-reported primary completion (est.)
Trials
Open trials first, then by primary completion date. Phases: Phase 3: 1, Observational: 2. "est." marks the sponsor's estimated date; CTIS search results don't include primary completion dates. Registry sponsor names grouped here: Sumitomo Pharma Switzerland GmbH.
| ID | Title | Condition | Lead sponsor | Phase | Status | Primary completion | Enrolment | Site countries |
|---|---|---|---|---|---|---|---|---|
| NCT05862272 ClinicalTrials.gov | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis | Endometriosis | Sumitomo Pharma Switzerland GmbH | Phase 3 | Recruiting | Jul 2029 (est.) | 1,000 | United States |
| NCT05739123 ClinicalTrials.gov | Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring | Endometriosis | Sumitomo Pharma Switzerland GmbH | Observational | Recruiting | May 2033 (est.) | 728 | United States |
| NCT05739136 ClinicalTrials.gov | MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy | Endometriosis | Sumitomo Pharma Switzerland GmbH | Observational | Active, not recruiting | May 2027 (est.) | 530 | United States |
See also: upcoming women's-health trial readouts · Endometriosis trials · PCOS trials · Menopause trials
Free weekly digest
Track women's-health pipelines every Monday
New trials, phase changes, stopped trials and new sponsors across the conditions we track, with registry links.
Your ticks help us prioritise what to build. They don't commit you to anything, and no payment is taken.
Want biotech news too? Closewire: nightly recap of what moved in Tech and Health stocks, plus a free Sunday weekly. Subscribe to Closewire →
Business research data, not medical advice. TrialsForHer summarises public registry records from ClinicalTrials.gov and the EU Clinical Trials Information System (CTIS) for professional and research use. Registry entries can be incomplete or out of date, and dates marked "est." are the sponsor's own estimates. Always check the official record. This isn't a way to enrol in a study; patients and carers should talk to their clinician or the study team listed on the registry.